VLON, plunged significantly after the company announced that its pivotal SEAL study evaluating ADAIR failed to achieve its main goal. Vallon’s lead investigational product candidate, ...

Is VLON a good stock to buy? Hedge funds were becoming hopeful. The number of long hedge fund bets rose by 3 lately. Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) was in 3 hedge funds’ portfolios ...

Vallon Pharmaceuticals, Inc. (VLON) closed on Friday at $0.4625 with a gain of $0.1945 or +72.57%. VLON didn't stop there and went on to add another 25.41% after the market closed. In terms of ...

Find the latest analyst research for Vallon Pharmaceuticals Inc. Common Stock (VLON) at Nasdaq.com.

Shares of clinical-stage biopharmaceutical company, Vallon Pharmaceuticals, Inc. VLON, plunged significantly after the company announced that its pivotal SEAL study evaluating ADAIR failed to achieve ...

Vallon Pharmaceuticals (NASDAQ:VLON) stock is rocketing higher on Wednesday as investors react to news of a merger agreement with GRI Bio. According to a press release, GRI Bio will combine with a ...